EFM
SLS icon

E Fund Management’s SELLAS Life Sciences SLS Stock Holding History

E Fund Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$133K Buy
+31,354
New +$140K ﹤0.01% 465

Other funds holding SLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

E Fund Management's SLS Position: Q1 2026 in Review

E Fund Management opened a new position in SELLAS Life Sciences (SLS) in Q1 2026: 31,354 shares worth $133K. The stake represents ﹤0.01% of the portfolio and ranks #465 among its holdings.

160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

  • E Fund Management held 31,354 shares of SELLAS Life Sciences worth $133K as of Q1 2026.
  • SELLAS Life Sciences was a new E Fund Management position in Q1 2026.
  • SELLAS Life Sciences made up ﹤0.01% of E Fund Management's portfolio in Q1 2026, its #465 holding.
  • 160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.